UnitedHealthcare |
Soliqua (insulin glargine-lixisenatide) |
Hormones : Drugs for Diabetes |
- Hemophilia B (Factor IX):
Duration: 1 year(s)
Documented Diagnosis: No
Reauthorization Required: No
Duration of Reauthorization: N/A
Dosing Limit(s): N/A
Treatment Center Required: No
|